DTIL
Precision BioSciences Inc
6.20$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| 15.5% | 22.1% | 8.1% | 2.8% | 175.5% | 118.7% | – | 3,866.7% | 5,184.6% | 2.0% | – | – | – | |
| 84.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | |
| 113.2% | 190.2% | 75.9% | 34.5% | 2,271.5% | 2,493.3% | 46,855.2% | 70,933.3% | 102,707.7% | 42.3% | 121.0% | – | 118.3% | |
| 73.4% | 121.3% | 47.9% | 17.1% | 1,522.0% | 1,501.1% | 29,493.1% | 50,705.6% | 56,369.2% | 21.1% | 62.8% | – | 62.4% | |
| 178.7% | 311.6% | 123.8% | 51.6% | 3,793.6% | 3,994.4% | 76,348.3% | 121,638.9% | 159,076.9% | 63.4% | 183.7% | – | 180.8% | |
| -94.2% | -211.6% | -23.8% | 48.4% | -3,693.6% | -3,894.4% | -76,248.3% | -121,538.9% | -158,976.9% | 36.6% | -83.7% | – | -80.8% | |
| 4.4% | 8.2% | 3.3% | 1.1% | 44.4% | 61.4% | 1,220.7% | 1,988.9% | 2,784.6% | 1.0% | 2.9% | – | 2.9% | |
| -92.3% | -190.9% | 48.8% | 65.6% | -2,851.6% | -2,781.3% | -70,913.8% | -130,666.7% | -167,476.9% | 56.3% | -170.2% | – | -119.0% | |
| -40.6% | 40.6% | 7.9% | -2.8% | 666.5% | -0.3% | – | – | – | – | – | – | – | |
| -126.0% | -231.4% | 48.8% | 65.6% | -2,851.6% | -2,781.3% | -70,913.8% | -130,666.7% | -167,476.9% | 58.9% | -170.2% | – | -117.0% | |
| -72.4% | -160.5% | 60.2% | 69.5% | -2,631.6% | -2,601.3% | -67,262.1% | -124,811.1% | -159,507.7% | 59.3% | -161.4% | – | -111.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.